NFIL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.034800E-01
Normal-vs-Stage2
8.350400E-01
Normal-vs-Stage3
4.898400E-01
Normal-vs-Stage4
9.453600E-01
Stage1-vs-Stage2
2.525000E-01
Stage1-vs-Stage3
6.287400E-01
Stage1-vs-Stage4
5.875600E-01
Stage2-vs-Stage3
5.259500E-03
Stage2-vs-Stage4
7.228800E-01
Stage3-vs-Stage4
4.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.171200E-01
Normal-vs-AfricanAmerican
7.546000E-01
Normal-vs-Asian
4.782000E-01
Caucasian-vs-AfricanAmerican
7.464200E-01
Caucasian-vs-Asian
1.715230E-01
AfricanAmerican-vs-Asian
1.529240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.927000E-01
Normal-vs-Female
8.676000E-01
Male-vs-Female
4.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.222400E-01
Normal-vs-Age(41-60Yrs)
4.786400E-01
Normal-vs-Age(61-80Yrs)
7.390400E-01
Normal-vs-Age(81-100Yrs)
8.624200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.772400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.590600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.234800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.396300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.959800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.423600E-01
Normal-vs-Daily Drinker
9.981600E-01
Normal-vs-Weekly Drinker
9.747200E-01
Normal-vs-Occasional Drinker
7.227400E-01
Normal-vs-Social Drinker
9.283000E-01
Non Drinker-vs-Daily Drinker
6.678600E-01
Non Drinker-vs-Weekly Drinker
7.669800E-01
Non Drinker-vs-Occasional Drinker
7.810000E-01
Non Drinker-vs-Social Drinker
5.746200E-01
Daily Drinker-vs-Weekly Drinker
9.529200E-01
Daily Drinker-vs-Occasional Drinker
5.017600E-01
Daily Drinker-vs-Social Drinker
8.613800E-01
Weekly Drinker-vs-Occasional Drinker
6.085400E-01
Weekly Drinker-vs-Social Drinker
8.396000E-01
Occasional Drinker-vs-Social Drinker
4.269000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.427600E-01
Normal-vs-Grade 2
8.459000E-01
Normal-vs-Grade 3
8.329400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.993700E-02
Grade 1-vs-Grade 3
1.543580E-01
Grade 1-vs-Grade 4
7.427600E-01
Grade 2-vs-Grade 3
7.860800E-01
Grade 2-vs-Grade 4
8.459000E-01
Grade 3-vs-Grade 4
8.329400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.467800E-01
Normal-vs-NonDiabetic
9.787600E-01
Diabetic-vs-NonDiabetic
7.732800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.287000E-01
Normal-vs-NoPancreatitis
9.368400E-01
Pancreatitis-vs-NoPancreatitis
8.146400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.209000E-01
Normal-vs-N1
7.875400E-01
N0-vs-N1
3.087500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.118200E-01
Normal-vs-TP53-NonMutant
7.126400E-01
TP53-Mutant-vs-TP53-NonMutant
7.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
